Commission Implementing Decision (EU) 2018/1099 of 1 August 2018 amending Annex XI to Council Directive 2003/85/EC as regards the list of laboratories authorised to handle live foot-and-mouth disease virus and amending Commission Implementing Decision (EU) 2018/136 as regards the denomination of the designated European Union reference laboratory for foot-and-mouth disease (notified under document C(2018) 4987) (Text with EEA relevance.)
Date: 2018-08-01
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: animal disease, infectious disease, research body, veterinary inspection, veterinary medicine




L_2018197EN.01001101.xml










3.8.2018   


EN


Official Journal of the European Union


L 197/11








            COMMISSION IMPLEMENTING DECISION (EU) 2018/1099
of 1 August 2018
         
amending Annex XI to Council Directive 2003/85/EC as regards the list of laboratories authorised to handle live foot-and-mouth disease virus and amending Commission Implementing Decision (EU) 2018/136 as regards the denomination of the designated European Union reference laboratory for foot-and-mouth disease


(notified under document C(2018) 4987)


(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Council Directive 2003/85/EC of 29 September 2003 on Community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC (1), and in particular Articles 67(2) and 69(1) thereof,

Whereas:







(1)


Directive 2003/85/EC sets out the minimum control measures to be applied in the event of an outbreak of foot-and-mouth disease and certain preventive measures aimed at increasing the awareness and preparedness of the competent authorities and the farming community concerning that disease.












(2)


The preventive measures set out in Directive 2003/85/EC include the requirement that the handling of live foot-and-mouth disease virus for research, diagnosis or vaccine manufacturing is carried out only in approved laboratories listed in Annex XI to that Directive.












(3)


Part A of Annex XI to Directive 2003/85/EC lists the national laboratories authorised to handle live foot-and-mouth disease virus for research and diagnostic purposes. Part B of that Annex lists the laboratories authorised to handle live foot-and mouth disease virus for vaccine production and related research.
The Netherlands has submitted a request to the Commission to change the name of its national laboratory for foot-and-mouth disease listed in Part A of Annex XI to Directive 2003/85/EC to ‘Wageningen Bioveterinary Research (WBVR), Lelystad’, due to organisational changes.
Belgium has also submitted a request to the Commission to change the name of its national laboratory for foot-and-mouth disease listed in Part A of Annex XI to Directive 2003/85/EC. The Belgian national laboratory for foot-and-mouth disease, the Veterinary and Agrochemical Research Centre (CODA-CERVA), has now become part of the new Belgian federal research centre, Sciensano, following a merge of the CODA-CERVA and the Scientific Institute of Public Health (WIV-ISP), which took effect on 1 April 2018. Sciensano has taken over all the rights and duties of its predecessors, including those of the CODA-CERVA.
Greece has submitted a request to the Commission to complete the name of its national laboratory for foot-and-mouth disease listed in Part A of Annex XI to Directive 2003/85/EC, which is also responsible for the diagnosis of rickettsial infections.












(4)


The Pirbright Institute, which is located in the United Kingdom, provides the services of a national reference laboratory for foot-and-mouth disease to Bulgaria, Croatia, Estonia, Finland, Ireland, Latvia, Lithuania, Malta, Portugal, Slovenia, Sweden and the United Kingdom, and it is duly listed as such in Part A of Annex XI to Directive 2003/85/EC. As a consequence of the United Kingdom's notification in accordance with Article 50 of the Treaty on European Union, the United Kingdom will no longer be a Member State of the European Union as of 30 March 2019. In accordance with Article 68(2), the Pirbright Institute may no longer provide the services of a national reference laboratory for foot-and-mouth disease to Bulgaria, Croatia, Estonia, Finland, Ireland, Latvia, Lithuania, Malta, Portugal, Slovenia and Sweden after the date of 29 March 2019.












(5)


For the reasons of legal certainty, it is important to keep the list of national laboratories for foot-and-mouth disease set out in Part A of Annex XI to Directive 2003/85/EC updated. Therefore, it is necessary to amend the name of the respective national laboratories in Belgium, in the Netherlands and in Greece and to indicate the date of withdrawal of the United Kingdom from the European Union as the date until which the Pirbright Institute may provide the services of a national reference laboratory for foot-and-mouth disease to other Member States and until which other Member State may use the services of the Pirbright institute as a national reference laboratory for foot-and-mouth disease.












(6)


Following organisational changes affecting the laboratory authorised to handle live foot-and-mouth disease virus for vaccine production listed in Part B of Annex XI to Directive 2003/85/EC, the Netherlands has submitted a request to the Commission to change the name of that laboratory situated on its territory to ‘Boehringer Ingelheim Animal Health Netherlands BV’.












(7)


Annex XI to Directive 2003/85/EC should therefore be replaced accordingly.












(8)


Commission Implementing Decision (EU) 2018/136 (2) designated the consortium ANSES & CODA-CERVA set up by the Laboratory for Animal Health of the Agency for Food, Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France, and the Veterinary and Agrochemical Research Centre (CODA-CERVA), Uccle, Belgium, as the European Union reference laboratory for foot-and-mouth disease. It is necessary to amend that Implementing Decision, so that it refers to Sciensano, instead of CODA-CERVA. Implementing Decision (EU) 2018/136 should therefore be amended accordingly.












(9)


The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,





HAS ADOPTED THIS DECISION:



Article 1
Annex XI to Directive 2003/85/EC is replaced in accordance with the Annex to this Decision.


Article 2
Article 1 of Implementing Decision (EU) 2018/136 is replaced by the following:


‘Article 1
The consortium ANSES & SCIENSANO set up by the Laboratory for Animal Health of the Agency for Food, Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France, and the Laboratory for Exotic Viruses and Particular Diseases of the federal research centre Sciensano, Uccle, Belgium, is hereby designated as the European Union reference laboratory for foot-and-mouth disease for an undetermined period.’




Article 3
This Decision is addressed to the Member States.




Done at Brussels, 1 August 2018.


For the Commission

Vytenis ANDRIUKAITIS
            

Member of the Commission






(1)  
            OJ L 306, 22.11.2003, p. 1.

(2)  Commission Implementing Decision (EU) 2018/136 of 25 January 2018 designating the European Union reference laboratory for foot-and-mouth disease and amending Annex II to Council Directive 92/119/EEC as regards the European Union reference laboratory for swine vesicular disease (OJ L 24, 27.1.2018, p. 3).




ANNEX
Annex XI to Directive 2003/85/EC is replaced by the following:



‘ANNEX XI
PART A

National laboratories authorised to handle live foot-and-mouth disease virus









Member State where laboratory is located


Laboratory


Member States using the services of laboratory




ISO code


Name




AT


Austria


Österreichische Agentur für Gesundheit und Ernährungssicherheit
Veterinärmedizinische Untersuchungen Mödling


Austria




BE


Belgium


Laboratory for Exotic Viruses and Particular Diseases of the federal research centre Sciensano, Uccle


Belgium
Luxembourg




CZ


Czech Republic


Státní veterinární ústav Praha, Praha


Czech Republic




DE


Germany


Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit,
Greifswald — Insel Riems


Germany
Slovakia




DK


Denmark


Danmarks Tekniske Universitet, Veterinærinstituttet, Afdeling for Virologi, Lindholm
Danish Technical University, Veterinary Institute, Department of Virology, Lindholm


Denmark
Finland
Sweden




EL


Greece


Διεύθυνση Κτηνιατρικού Κέντρου Αθηνών, Τμήμα Μοριακής Διαγνωστικής, Αφθώδους Πυρετού, Ιολογικών, Ρικετσιακών και Εξωτικών Νοσημάτων, Αγία Παρασκευή Αττικής


Greece




ES


Spain








—


Laboratorio Central de Sanidad Animal, Algete, Madrid










—


Centro de Investigación en Sanidad Animal (CISA), Valdeolmos, Madrid






Spain




FR


France


Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Laboratoire de santé animale de Maisons-Alfort


France




HU


Hungary


Nemzeti Élelmiszerlánc-biztonsági Hivatal, Állategészségügyi Diagnosztikai Igazgatóság (NÉBIH-ÁDI), Budapest


Hungary




IT


Italy


Istituto zooprofilattico sperimentale della Lombardia e dell'Emilia-Romagna, Brescia


Italy
Cyprus




NL


Netherlands


Wageningen Bioveterinary Research (WBVR), Lelystad


Netherlands




PL


Poland


Zakład Pryszczycy Państwowego Instytutu Weterynaryjnego — Państwowego Instytutu Badawczego, Zduńska Wola


Poland




RO


Romania


Institutul de Diagnostic și Sănătate Animală, București


Romania




UK


United Kingdom


The Pirbright Institute


United Kingdom
Bulgaria (1)

Croatia (1)

Estonia (1)

Finland (1)

Ireland (1)

Latvia (1)

Lithuania (1)

Malta (1)

Portugal (1)

Slovenia (1)

Sweden (1)





PART B

Laboratories authorised to handle live foot-and-mouth disease virus for vaccine production








Member State where laboratory is located


Laboratory




ISO code


Name




DE


Germany


Intervet International GmbH/MSD Animal Health, Köln




NL


Netherlands


Boehringer-Ingelheim Animal Health Netherlands BV, Lelystad




UK


United Kingdom


Merial, S.A.S., Pirbright Laboratory, Pirbright (2)







            ’
         


(1)  Use of services in accordance with Article 68(2) until 29 March 2019.

(2)  Applicable until 29 March 2019